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Background: The aim of this study was to define the optimal target concentration of remifentanil which effectively 
achieves conscious sedation without significant vital sign changes and side effects during spinal anesthesia. 
Methods: Sixty patients underwent spinal anesthesia with 0.5% hyperbaric bupivacaine (8-16 mg), and were infused 
with a target controlled infusion (TCI) of remifentanil at 1.0 ng/ml (group R10, n = 15), 2.0 ng/ml (group R20, n = 15), 
3.0 ng/ml (group R30, n = 15), and 3.5 ng/ml (group R35, n = 15). Observer’s assessment of alertness/sedation (OAA/S) 
scale, the bispectral index (BIS), anxiety levels and infusion rate of remifentanil were monitored during the operation.
Results: OAA/S scale was significantly lower in groups R30 (3.96) and R35 (3.34) than groups R10 (4.31) and R20 (4.26). 
Incidence of intraoperative respiratory depression events, post operative nausea and vomiting were significantly 
higher in group R35 than the other groups. There were no significant differences in BIS, anxiety level and incidences 
of recall of the operative procedure among the groups. 
Conclusions: We conclude that the TCI of remifentanil at 3.0 ng/ml produces an effective sedation and anti-anxiety 
effects without significant side effects during spinal anesthesia. (Korean J Anesthesiol 2011; 61: 195-200)
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Introduction
Regional anesthesia leaves patients awake, anxious and 
it can also cause discomfort and stress during the operative 
procedure. To minimize these complaints, sedatives such 
as midazolam or propofol may be used singly. In addition, 
combination administration with opioids including alfentanil 
or remifentanil can help the patients to be relaxed and coope-
rative.
Propofol is commonly used for conscious sedation during 
local or regional anesthesia. Disadvantages of propofol include 
moderate pain during intravenous injection and involuntary 
movement during the operation. But, it produces an excellent 
sedative effect at a blood concentration of 0.9 μg/ml during 
spinal anesthesia. This value is significantly lower than 1.8 μg/
ml during local anesthesia for conscious sedation [1]. Because 
spinal anesthesia itself potentiates the sedative effects due to 
the deafferentation mechanism in the early phase as well as a 196 www.ekja.org
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direct action of local anesthetics to the brain in the late phase [2], 
requirement of the sedatives and anesthestics can be reduced 
during spinal anesthesia [3]. Therefore, a single infusion of 
remifentanil has a similar effect to combination use with a small 
dose of sedatives for conscious sedation [4]. This method is able 
to reduce the side effect of propofol. 
However, remifentanil can cause respiratory depression, 
nausea and vomiting which are dose-related [4]. Therefore, it is 
necessary to study the optimal concentrations of remifentanil 
that are effective in achieving proper sedation as well as 
minimizing side effects. 
The purpose of this study was to determine whether a 
single infusion of remifentanil was useful for conscious 
sedation during spinal anesthesia by evaluating the sedative 
score, anxiety level and the incidence of side effects while 
patients were infused with a target controlled infusion (TCI) 
of remifentanil at concentration of 1.0 ng/ml, 2.0 ng/ml, 3.0 
ng/ml and 3.5 ng/ml. We also investigated the optimal target 
concentration of remifentanil which effectively achieves 
conscious sedation without significant changes in vital signs 
and side effects. 
Materials and Methods
A total of 60 patients (men and women), aged 20 to 65 
years, who were scheduled for elective surgery under spinal 
anesthesia and had a ASA physical status I and II, were enrolled 
into the study after written informed consent was obtained from 
each patient. The patients were divided into four groups of 15 
persons each. The following patients were excluded: those with 
significant cardiac, hepatic, renal or psychiatric disease, those 
with prior abuse of opioids or sedatives and those currently using 
anti-hypertensive drugs. Patients with heart rate lower than 50 or 
higher than 100 beats/min and systolic blood pressure higher 
than 160 mmHg or lower than 80 mmHg at pre-induction were 
also excluded.
All patients did not receive any premedication and at their 
arrival into the operating room they were intravenously injected 
with 12 ml/kg Hartman solution, while oxygen was provided 
at 5 L/min using face mask ventilation. Electrocardiogam 
(EKG), heart rate (HR) and oxygen saturation were monitored 
continuously and non-invasive blood pressure (BP) was 
measured at 5 minute intervals until the end of the operation. 
The bispectral index scale (BIS) was assessed continuously by a 
sensor placed on the patient's forehead and a BIS monitor (A-
2000 BIS monitor, Aspect Medical System, USA).
We performed spinal anesthesia with 8-16 mg of 0.5% 
hyperbaric bupivacaine and the level of sensory block was 
evaluated 10-12 minutes after the induction of anesthesia. 
When the operation began, remifentanil infusion started with a 
target-controlled infusion system (Orchestra
Ⓡ, Fresenius Vial, 
France) using Minto’s model. The target effect-site concen-
tration of remifentanil was set at 1.0 ng/ml, 2.0 ng/ml, 3.0 ng/ml 
and 3.5 ng/ml in groups R10, R20, R30 and R35, respectively. 
We assessed the degree of sedation using BIS and observer’s 
assessment of alertness/sedation (OAA/S) scale (5: completely 
alert, 4: drowsy, 3: with eyes close, but responsive to verbal 
stimulation promptly, 2: with eyes close, only responsive to 
physical stimulation, 1: unresponsive to physical stimulation) 
and also measured anxiety (1: anxious and uncooperative, 2: 
not completely cooperative, with emotional change 3: coopera-
tive and able to perform the operation) at 5 minute intervals. 
Infusion rate (μg/kg/min) was calculated using the total infusion 
dose of remifentanil divided by patient weight per infusion time 
and these values did not need to be compared among the groups 
because they were proportional to their setting concentration. 
After the cessation of remifentanil infusion, response to verbal 
commands was checked. An hour after the end of the operation, 
we noted incidence of recall of the operative procedure in 
a recovery room. We recorded the remifentanil-associated 
side effects such as hypotension, bradycardia and respiratory 
depression during the intraoperative and postoperative period. 
If BP decreased to 30% of the first measured BP, this was defined 
as hypotension and a HR below 50 beats/min was defined as 
bradycardia. If the oxygen saturation decreased below 95% with 
oxygen given a 5 L/min, then it was regarded as respiratory 
depression. In addition, we checked whether confusion, heada-
che, dizziness, nausea and vomiting developed in recovery 
room. HR, systolic arterial pressure (SAP) and diastolic arterial 
pressure (DAP) were measured at 5 minute intervals for an hour 
after initiation of remifentanil infusion and these values were 
compared among the groups.
All results were shown as mean ± standard error (SE) and 
analysis of variance (ANOVA) was performed on the demo-
graphic data, using the one-way ANOVA among the groups. A 
Kruskal-Wallis test was applied to compare sedation scores. 
For a comparison of side effects during the intraoperative 
and postoperative period, a x
2-test was applied. For HR, SAP, 
DAP and sedation score measurements, Tukey’s was applied 
to determine differences in the groups. P values < 0.05 were 
considered statistically significant.
Results
Among the groups, there were no significant differences 
in sex, age, weight and height, there were also no significant 
differences in the dose of administrated bupivacaine and the 
level of anesthesia (Table 1). 
The OAA/S score in group R35 were significantly lower than 
in the other three groups and the value in group R30 was also 197 www.ekja.org
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significantly lower than in groups R10 and R20 (P < 0.05). There 
were no significant differences in BIS and the anxiety scale, and 
BIS was overly high even in the sedative condition. The infusion 
rate of remifentanil was 0.04 μg/kg/min, 0.08 μg/kg/min, 0.13 
μg/kg/min and 0.15 μg/kg/min on average in groups R10, R20, 
R30 and R35, respectively. Ninety-five percent of the patients 
responded to a verbal command immediately after the stop of 
remifentanil infusion and there was no significant difference 
among the groups. Incidence of recall of the operative 
procedure was significantly higher in group R10 than in the 
other groups (P < 0.05) (Table 2).
With respect to hemodynamic changes during the operation, 
HR showed no significant differences among the groups (Fig. 1). 
SAP decreased significantly in group R30 at 40-50 minutes after 
the induction of anesthesia compared with group R10 (Fig. 2), 
Table 1. Patient Characteristics
R10 (n = 15) R20 (n = 15) R30 (n = 15) R35 (n = 15)
Sex (M/F)
Age (yr)
Weight (kg)
Height (cm)
Duration of surgery (min)
Bupivacaine used (mg)
Level of anesthesia
11/4
45.4 ± 2.5
66.3 ± 2.5
166.8 ± 2.3
72 ± 6.5
10.5 ± 0.3
T6 (T4-10)
13/2
42.8 ± 3.9
70.9 ± 2.5
170.1 ± 2.0
66.3 ± 4.9
10.3 ± 0.2
T6 (T4-10)
11/4
48.7 ± 2.4
64.4 ± 2.0
165.1 ± 1.8
66.1 ± 4.4
10.8 ± 0.3
T6 (T4-10)
13/2
43.2 ± 4.5
68.2 ± 3.3
167.0 ± 2.6
77.1 ± 5.8
10.9 ± 0.3
T6 (T4-10)
Values are mean ± SE or median (range). R10, R20, R30 and R35 represent target concentrations of remifentanil (1.0 ng/ml, 2.0 ng/ml, 3.0 ng/ml 
and 3.5 ng/ml, respectively) in each of target controlled infusion groups. 
Table 2. Sedation Data
R10 (n = 15) R20 (n = 15) R30 (n = 15) R35 (n = 15)
OAA/S scale
Anxiety level
Bispectral index
Infusion rate (μg/kg/min)
End of infusion to response 
  to verbal command (n)
Recall of operative procedure (n)
4.31 (5-3)
  3.0 (2-3)
93.9 ± 0.4
0.04 ± 0.002
15
   13
‡
4.26 (5-3)
3.0 (2-3)
92.3 ± 0.6
0.08 ± 0.003
15
10
3.96 (5-2)*
3.0
92.5 ± 0.7
0.13 ± 0.003
14
  8
3.34 (5-2)*,†
3.0
88.6 ± 0.8
0.15 ± 0.006
13
  8
Values are mean ± SE or median (range). R10, R20, R30 and R35 represent target concentrations of remifentanil (1.0 ng/ml, 2.0 ng/ml, 3.0 ng/ml 
and 3.5 ng/ml, respectively) in each of target controlled infusion groups. *P < 0.05 compared with group R10 and R20. 
†P < 0.05 compared with 
group R10, R20 and R30. 
‡P < 0.05 compared with group R20, R30 and R35.
Fig. 1. Changes of heart rate are shown up to 60 min after admini-
stration of remifentanil. Data are expressed as mean ± SE. R10, R20, 
R30 and R35 represent target concentrations of remifentanil of 1.0 
ng/ml, 2.0 ng/ml, 3.0 ng/ml and 3.5 ng/ml, respectively in each of 
target controlled infusion group.
Fig. 2. Changes of systolic arterial pressure are shown up to 60 min 
after administration of remifentanil. Data are expressed as mean 
± SE. R10, R20, R30 and R35 represent target concentrations of 
remifentanil 1.0 ng/ml, 2.0 ng/ml, 3.0 ng/ml and 3.5 ng/ml, respec-
tively in each of target controlled infusion groups. *Group R30 was 
significantly different compared with group R10 (P < 0.05).198 www.ekja.org
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but DAP showed no significant differences among the groups 
(Fig. 3).
OAA/S scores were significantly lower in group R35 than 
in groups R10, R20 and R30 at 50-60 minutes after induction. 
Group R30 showed a significant reduction in the OAA/S scale 
compared to group R10 at 5-10 minutes, 35-45 minutes and 
55 minutes after induction (Fig. 4). 
Hypotension was observed in 7% of R20 and 13% of R35 and 
bradycardia seen in 13% of R20 and 13% of R35 patients during 
the operation. Intraoperative respiratory depression developed 
in 20% of R30 and 47% of R35 patients. Among these, only the 
incidence in respiratory depression was significantly higher in 
group R35 compared to the other groups (P < 0.05). Involuntary 
movement was absent during the operations, so there were no 
significant differences among the groups.
Dizziness in recovery room was more frequent in the group 
R35 (30%) than in the other three groups (6%), but this did not 
reach statistical significance. Incidence of nausea and vomiting 
in group R35 was significantly higher than in the other three 
groups (P < 0.05). There were no significant differences between 
the groups for confusion and headaches when monitored in the 
recovery room (Table 3).
Discussion
Conscious sedation is achieved by administering a drug 
that depresses the central nervous system (CNS) and it induces 
a state that allows the patients to tolerate procedures while 
easily maintaining responses to command [5]. For the patients 
who receive regional anesthesia, conscious sedation facilitates 
the procedure by reducing anxiety, pain and noxious stimuli 
while allowing maintenance of airway control independently. 
In addition, this method keeps the protective reflex, stabilizes 
vital signs and better promotes recovery. Conscious sedation is 
much more safe than deep sedation because the complications 
around the operation are rare compared to deep sedation 
which has incidence rates ranging from 25-75% [6]. Therefore, 
conscious sedation is apprpriate for patients during regional 
anesthesia. 
Spinal and epidural anesthesia reduce the requirements for 
intravenous or inhaled anesthetics [3] due to the decrease of 
afferent inputs in the reticular activating system [7]. Midazolam 
[8], isoflurane [9], sevoflurane [10] have therefore been reported 
to have decreased use during anesthesia. Particularly with 
spinal anesthesia using bupivacaine, it has been reported that 
Fig. 3. The changes of diastolic arterial pressure are shown up to 60 
min after administration of remifentanil. Data are expressed as mean 
± SE. R10, R20, R30 and R35 represent target concentrations of remi-
fentanil 1.0 ng/ml, 2.0 ng/ml, 3.0 ng/ml and 3.5 ng/ml, respectively 
in each of target controlled infusion groups.
Fig. 4. The changes of sedation score are shown up to 60 min after 
administration of remifentanil. Data are expressed as mean ± SE. 
R10, R20, R30 and R35 represent target concentrations of remifentanil 
1.0 ng/ml, 2.0 ng/ml, 3.0 ng/ml and 3.5 ng/ml, respectively in each 
of target controlled infusion groups. *Group R35 was significantly 
different compared with group R10, R20 and R30 (P < 0.05), 
†Group 
R30 was significantly different compared with group R10 (P < 0.05).
Table 3. Incidences of Perioperative Side Effects
R10 
(n = 15)
R20 
(n = 15)
R30 
(n = 15)
R35 
(n = 15)
Intraoperative
    Hypotension
    Bradycardia
    SpO2 < 95%
    Incoluntary movement
Recovery
    Confusion
    Headache
    Dizziness
    Nausea and vomiting
0
0
0
0
0
0
1
2
1
2
0
0
0
1
1
4
0
2
3
0
1
1
1
4
2
4
  7*
0
0
1
5
  9*
R10, R20, R30 and R35 represent target concentrations of remifentanil 
(1.0 ng/ml, 2.0 ng/ml, 3.0 ng/ml and 3.5 ng/ml, respectively) in each 
of target controlled infusion groups.  *P < 0.05 compared with group 
R10, R20 and R30.199 www.ekja.org
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a high level block was associated with increased sedation [7]. 
In our study, bupivacaine was used during spinal anesthesia, 
and dose as well as the level of block showed no significant 
differences among the groups, so we could ignore the difference 
of sedation score caused by the level of block.
Propofol, which is a commonly used sedative during con-
scious sedation, allows the depth of anesthesia to change 
immediately by rapid control of the blood concentration using 
TCI [1]. Despite an excellent amnesic effect and low incidence 
of nausea and vomiting, propofol has no analgesic effect and 
produces undesirable effects such as involuntary movement. 
Its powerful amnesic effect is also sometimes undesirable if the 
patient wants to know about the procedures during operation 
[11]. 
Opioids are commonly used in monitored anesthesia care 
(MAC) and for pain relief during regional or general anesthesia. 
Of these, remifentanil which is a μ receptor agonist, not only has 
rapid onset of analgesic action but also has a fast offset of action 
due to non-specific esterases. Its half-life is 9.5 minutes [12] and 
context-sensitive half-time remains consistent even after long-
term infusions [13]. The unique properties of remifentanil result 
in hemodynamic stability with analgesic effects necessary for 
outpatient anesthesia [14]. Mullejans et al. [15] reported that 
only 30% of the patients on long-term mechanical ventilation 
in the ICU demanded sedatives like propofol to be added with 
remifentanil, while the other patients could stay in comfort with 
remifentanil by itself. Since most of the distress of the patients 
was due to pain, analgesia-based sedation techniques were 
actually more useful to keep the patients comfortable than 
hypnotic-based sedation [15]. In other words, it was suggested 
that the manipulation of the analgesic dose by adding a sedative 
only might be more desirable than minimizing the dose of 
analgesics for optimal sedation. Hwang et al. [16] also reported 
that analgesia-based sedation using remifentanil satisfied the 
patients and the operators during endoscopic discectomy 
under conscious sedation because of an adequate analgesic 
effect while avoiding excessive sedation [16].
Fortunately, there was no patient who complained of pain 
during the surgery in our study. But if there are patients who 
feel the pain and discomfort due to an low block levels from 
unsuccessful spinal anesthesia or protracted operation, anal-
gesics must be preferable to excessive sedatives for pain relief. 
However remifentanil may reduce the patient’s satisfaction 
owing to respiratory depression, nausea, vomiting and low 
incidence of amnesia [17]. Mingus et al. [4] reported that, while 
remifentanil had better analgesic effects without excessive 
sedation than propofol, it had more frequent side effects 
including respiratory depression, nausea and vomiting, and 
they recommended dose reduction for elimination of these 
side effects. In a study by Akcaboy et al. [18], the patients and 
the operators using remifentanil were better satisfied than the 
group receiving propofol because of the adequate sedation, 
analgesia and rapid recovery during MAC for colonoscopy. They 
also reported respiratory depression as a typical complication 
of remifentanil and this was reduced by means of the low dose 
infusion of remifentanil. 
We tried to administer remifentanil solely without propofol 
for sedation under spinal anesthesia in this study based 
on the fact that spinal anesthesia reduces the requirement 
of intravenous sedatives due to decreased afferent inputs 
of the reticular activating system during spinal anesthesia, 
Consequently, a single infusion of remifentanil was found to be 
excellent in inducing a sedative effect. Remifentanil TCI at 3.0 
ng/ml and 3.5 ng/ml was responsible for significant decreases 
in OAA/S scores (3.96 and 3.34, respectively), similar to the 
OAA/S scores of 3 and 4 targeting conscious sedation. These 
scores were nearly identical to a value of 3.8 in a group using 
propofol TCI under spinal anesthesia for conscious sedation 
[1]. In other words, when OAA/S scores were used to assess the 
degree of sedation, the score for propofol TCI with 0.9 μg/ml 
was not significantly different compared to a remifentanil TCI at 
3.0 ng/ml and 3.5 ng/ml. But the BIS value of 92.5 and 88.6 were 
recorded in the remifentanil groups, while the propofol group’s 
BIS score was 73.4 [1]. These results showed that BIS could not 
reflect the degree of sedation when using remifentanil because 
BIS could not properly reflect sedation which was achieved by 
remifentanil or spinal anesthesia, whereas propofol-induced 
sedation could be reflected in BIS scores [19]. Most patients 
responded to a verbal command promptly after stopping the 
remifentanil infusion, so there was no risk of delayed recovery. 
The incidence of recall of the operative procedure was 53-86% 
which was significantly higher than the incidence rate of 15% 
in the group using propofol TCI [1]. There was no significant 
increase in the amnesic effect, remifentanil produced only 
analgesia without amnesia. 
HR, SAP and DAP decreased as the amount of remifentanil 
infusion increased, but there were no significant differences. 
These results showed that remifentanil could maintain hemo-
dynamic stability with only a minimal impact on cardiovascular 
system at the low concentrations for sedation. However, more 
studies are needed to investigate the hemodynamic changes in 
the elderly, in systemically ill patients and in groups at higher 
concentrations of remifentanil as well. 
Since common side effects of remifentanil including brady-
cardia, hypoxia (SpO2 < 95%), postoperative dizziness, nausea 
and vomiting were more frequent in the remifentanil TCI 
group receiving 3.5 ng/ml compared to the other groups, the 
adequate concentration of remifentanil for sedation during 
spinal anesthesia is thought to be 3.0 ng/ml. When respiratory 
depression developed, though, the patients recovered the SpO2 200 www.ekja.org
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value higher than 95% within 1-2 minutes by encouraging the 
patients to breathe deeply. For hypotension, fluid loading was 
performed initially and then low BP recovered within 5 minutes 
without the need of ephedrine. Bradycardia recovered within 
5 minutes without any particular treatment. And postoperative 
nausea and vomiting were diminished after intravenous 
administration with 4 mg of ondansetron.
In conclusion, remifentanil produced the excellent sedative 
effect as an alternative to propofol. However the more powerful 
sedative effect was associated with the higher incidences of side 
effects, especially respiratory depression, nausea and vomiting 
so it is necessary carefully chose the doses for administration. 
We conclude that a single infusion of remifentanil is useful 
during spinal anesthesia using hyperbaric bupivacaine, and 
the TCI of remifentanil at 3.0 ng/ml is thought to be most 
appropriate considering the minimal hemodynamic change 
and side effects.
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